Jones Hill Capital »

Immunic shares owned by Jones Hill Capital

Quarter-by-quarter ownership of Immunic (IMUX) shares owned by Jones Hill Capital from 13F filings

Historical chart of Jones Hill Capital investment in Immunic

Tip: Access up to 7 years of quarterly data

All positions including Immunic held by Jones Hill Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunic by Jones Hill Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $8.3M 540k 15.37

More positions owned by Jones Hill Capital

BioMarin Pharmaceutical (BMRN)
Gilead Sciences (GILD)
Arcutis Biotherapeutics (ARQT)
Madrigal Pharmaceuticals (MDGL)
Bicara Therapeutics (BCAX)
Relmada Therapeutics (RLMD)
Trevi Therapeutics (TRVI)
Pharvaris N V (PHVS)
Xenon Pharmaceuticals (XENE)
Biosante Pharmaceuticals (ANIP)
Immunocore Hldgs Ads (IMCR)
Amylyx Pharmaceuticals (AMLX)
Insmed Com Par $.01 (INSM)
Nuvalent Inc-a (NUVL)
Capricor Therapeutics Com New (CAPR)

View all positions for Jones Hill Capital

Top funds holding Immunic

Standard Life Aberdeen
BVF
Millennium Management
Avidity Partners Management
Braidwell
Laurion Capital Management
Vanguard Capital Management
Jones Hill Capital
Woodline Partners
Soleus Capital Management
Propel Bio Management
Susquehanna International
Nantahala Capital Management
UBS Group
Geode Capital Management

View all funds holding Immunic